Rua Bioscience Limited (RUA.NZ)

0.0690 -0.0010 (-1.43%) At close: 12:57PM NZST

Rua Bioscience Limited

1 Commerce Place
Awapuni
Gisborne 4071
New Zealand
64 800 782 246
https://www.ruabio.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Panapa Ehau	Co-Founder & Executive Director	45k	N/A	N/A
Mr. Paul Naske	Chief Executive Officer	N/A	N/A	N/A
Tony Robinson	Compliance & Business Development Manager	N/A	N/A	N/A
Kerry Donovan	Communications Manager	N/A	N/A	N/A
Paul Woroniecki	Head of Quality	N/A	N/A	N/A
Mr. Len Walker	Head of Cultivation at Mangaoporo	N/A	N/A	N/A
Mr. John Sanders	Chief of Sales & Marketing of Australia	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in NZD.

Description

Rua Bioscience Limited engages in the research, development, and manufacturing of pharmaceutical products in New Zealand and internationally. It offers cannabinoid derived medicines. The company was formerly known as Hikurangi Cannabis Company Limited and changed its name to Rua Bioscience Limited in October 2019. Rua Bioscience Limited was founded in 2016 and is based in Gisborne, New Zealand.

Corporate governance

Rua Bioscience Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.